BZYR
Price
$0.03
Change
-$0.01 (-25.00%)
Updated
Aug 29 closing price
Capitalization
3.42M
RENB
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
47.69M
Interact to see
Advertisement

BZYR vs RENB

Header iconBZYR vs RENB Comparison
Open Charts BZYR vs RENBBanner chart's image
Burzynski Research Institute
Price$0.03
Change-$0.01 (-25.00%)
Volume$500
Capitalization3.42M
Renovaro
Price$0.21
Change-$0.00 (-0.00%)
Volume$2.63K
Capitalization47.69M
BZYR vs RENB Comparison Chart in %
Loading...
BZYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BZYR vs. RENB commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BZYR is a Hold and RENB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BZYR: $0.03 vs. RENB: $0.21)
Brand notoriety: BZYR and RENB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BZYR: 1% vs. RENB: 132%
Market capitalization -- BZYR: $3.42M vs. RENB: $47.69M
BZYR [@Biotechnology] is valued at $3.42M. RENB’s [@Biotechnology] market capitalization is $47.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BZYR’s FA Score shows that 0 FA rating(s) are green whileRENB’s FA Score has 0 green FA rating(s).

  • BZYR’s FA Score: 0 green, 5 red.
  • RENB’s FA Score: 0 green, 5 red.
According to our system of comparison, both BZYR and RENB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BZYR’s TA Score shows that 4 TA indicator(s) are bullish while RENB’s TA Score has 4 bullish TA indicator(s).

  • BZYR’s TA Score: 4 bullish, 5 bearish.
  • RENB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RENB is a better buy in the short-term than BZYR.

Price Growth

BZYR (@Biotechnology) experienced а -35.00% price change this week, while RENB (@Biotechnology) price change was -15.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RENB($47.7M) has a higher market cap than BZYR($3.42M). BZYR YTD gains are higher at: -16.129 vs. RENB (-74.458). BZYR has higher annual earnings (EBITDA): -1.35M vs. RENB (-56.89M). RENB has more cash in the bank: 1.63M vs. BZYR (821). BZYR (0) and RENB (0) have equivalent revenues.
BZYRRENBBZYR / RENB
Capitalization3.42M47.7M7%
EBITDA-1.35M-56.89M2%
Gain YTD-16.129-74.45822%
P/E RatioN/AN/A-
Revenue00-
Total Cash8211.63M0%
Total DebtN/A7.03M-
FUNDAMENTALS RATINGS
BZYR vs RENB: Fundamental Ratings
BZYR
RENB
OUTLOOK RATING
1..100
3354
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9393
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RENB's Valuation (98) in the Financial Conglomerates industry is in the same range as BZYR (99) in the null industry. This means that RENB’s stock grew similarly to BZYR’s over the last 12 months.

RENB's Profit vs Risk Rating (100) in the Financial Conglomerates industry is in the same range as BZYR (100) in the null industry. This means that RENB’s stock grew similarly to BZYR’s over the last 12 months.

RENB's SMR Rating (97) in the Financial Conglomerates industry is in the same range as BZYR (100) in the null industry. This means that RENB’s stock grew similarly to BZYR’s over the last 12 months.

RENB's Price Growth Rating (93) in the Financial Conglomerates industry is in the same range as BZYR (93) in the null industry. This means that RENB’s stock grew similarly to BZYR’s over the last 12 months.

RENB's P/E Growth Rating (100) in the Financial Conglomerates industry is in the same range as BZYR (100) in the null industry. This means that RENB’s stock grew similarly to BZYR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BZYRRENB
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
67%
Bullish Trend 10 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BZYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVNS12.660.31
+2.51%
Avanos Medical
BOH68.861.33
+1.97%
Bank of Hawaii Corp
MYSE1.910.03
+1.60%
Myseum Inc
USFD78.000.83
+1.08%
US Foods Holding Corp
KVHI5.740.03
+0.53%
KVH Industries

BZYR and

Correlation & Price change

A.I.dvisor tells us that BZYR and DWTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BZYR and DWTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BZYR
1D Price
Change %
BZYR100%
N/A
DWTX - BZYR
29%
Poorly correlated
+1.52%
CRNX - BZYR
21%
Poorly correlated
-1.15%
RENB - BZYR
20%
Poorly correlated
-4.09%
BVNRY - BZYR
10%
Poorly correlated
+0.23%
BIXT - BZYR
1%
Poorly correlated
+2.60%
More

RENB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with VRCA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
-4.09%
VRCA - RENB
37%
Loosely correlated
-1.34%
DTIL - RENB
36%
Loosely correlated
-0.40%
TNGX - RENB
34%
Loosely correlated
+1.94%
XBIT - RENB
32%
Poorly correlated
N/A
ENVB - RENB
29%
Poorly correlated
-3.81%
More